HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
301	21446 Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, et al. The ART of loss: A beta imaging in the evaluation of Alzheimer's disease and other dementias MOLECULAR NEUROBIOLOGY. 2008 AUG; 38 (1): 1-15	8	17	67	186
302	22446 Kell DB Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases BMC MEDICAL GENOMICS. 2009 JAN 8; 2: Art. No. 2	1	23	67	2468
303	24154 Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria LANCET NEUROLOGY. 2009 DEC; 8 (12): 1150-1157	7	17	67	93
304	25664 van Blitterswijk M, Landers JE RNA processing pathways in amyotrophic lateral sclerosis NEUROGENETICS. 2010 JUL; 11 (3): 275-290	2	2	67	244
305	26533 Xilouri M, Stefanis L Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 701-719	0	0	67	290
306	26922 Piguet O, Hornberger M, Mioshi E, Hodges JR Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management LANCET NEUROLOGY. 2011 FEB; 10 (2): 162-172	0	0	67	130
307	7809 Goedert M, Spillantini MG Tauopathies and alpha-synucleinopathies FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 65-86	2	2	66	85
308	7811 Buee L, Mailliot C, Bussiere T, Sergeant N, Buee-Scherrer V, et al. Neurodegenerative disorders with tauopathies: Mad tau diseases? FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 105-125	2	2	66	105
309	9061 Goedert M, Spillantini MG Tau gene mutations and neurodegeneration NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE. 2001; (67): 59-71	1	2	66	85
310	9195 Reed LA, Wszolek ZK, Hutton M Phenotypic correlations in FTDP-17 NEUROBIOLOGY OF AGING. 2001 JAN-FEB; 22 (1): 89-107	113	127	66	107
#	Date / Author / Journal	LCS	GCS	LCR	CR
311	11794 Golbe LI alpha-synuclein and Parkinson's disease PARKINSON'S DISEASE. 2003; 91: 165-174	7	9	66	93
312	12678 Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K The role of alpha-synuclein in Parkinson's disease: Insights from animal models NATURE REVIEWS NEUROSCIENCE. 2003 SEP; 4 (9): 727-738	69	103	66	93
313	12702 Dauer W, Przedborski S Parkinson's disease: Mechanisms and models NEURON. 2003 SEP 11; 39 (6): 889-909	243	861	66	235
314	17937 Abeliovich A, Beal MF Parkinsonism genes: culprits and clues JOURNAL OF NEUROCHEMISTRY. 2006 NOV; 99 (4): 1062-1072	11	39	66	118
315	20036 Strong MJ The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS. 2008; 9 (6): 323-338	15	22	66	213
316	20982 Turner BJ, Talbot K Transgenics, toxicity and therapeutics in rodent models of mutant SOD1- mediated familial ALS PROGRESS IN NEUROBIOLOGY. 2008 MAY; 85 (1): 94-134	31	80	66	438
317	22491 Jellinger KA Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 101-110	13	20	66	160
318	23147 Yin J, Chen RZ, Liu CL Nucleic acid induced protein aggregation and its role in biology and pathology FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5084-5106	0	0	66	189
319	23282 Yacoubian TA, Standaert DG Targets for neuroprotection in Parkinson's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 676-687	1	10	66	244
320	23454 Lu BW Recent advances in using Drosophila to model neurodegenerative diseases APOPTOSIS. 2009 AUG; 14 (8): 1008-1020	4	6	66	142
#	Date / Author / Journal	LCS	GCS	LCR	CR
321	24370 Martin LJ Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis JOURNAL OF ALZHEIMERS DISEASE. 2010; 20: S335-S356	0	0	66	204
322	24574 Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, et al. Total and phosphorylated tau protein as biological markers of Alzheimer's disease EXPERIMENTAL GERONTOLOGY. 2010 JAN; 45 (1): 30-40	5	5	66	111
323	25278 Shi M, Huber BR, Zhang J Biomarkers for Cognitive Impairment in Parkinson Disease BRAIN PATHOLOGY. 2010 MAY; 20 (3): 660-671	0	0	66	149
324	26847 Greggio E, Bisaglia M, Civiero L, Bubacco L Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? MOLECULAR NEURODEGENERATION. 2011 JAN 18; 6: Art. No. 6	0	0	66	124
325	9018 Cassimeris L, Spittle C Regulation of microtubule-associated proteins INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 210. 2001; 210: 163-226	13	96	65	483
326	10909 Takashima A Neurofibrillary tangles and neurodegenerative disease SEIKAGAKU. 2002 JUN; 74 (6): 461-470	0	0	65	83
327	11781 Botas J Neurodegenerative diseases: Insights from Drosophila and mouse models NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 85-103	0	0	65	106
328	18326 Martin LJ Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration REVIEWS IN THE NEUROSCIENCES. 2007; 18 (2): 115-136	6	12	65	163
329	18364 Kumar-Singh S, Van Broeckhoven C Frontotemporal lobar degeneration: Current concepts in the light of recent advances BRAIN PATHOLOGY. 2007 JAN; 17 (1): 104-113	30	34	65	117
330	19410 Haugarvoll K, Wszolek ZK, Hutton M The genetics of frontotemporal dementia NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 697-+	1	2	65	98
#	Date / Author / Journal	LCS	GCS	LCR	CR
331	21829 Woulfe J Nuclear bodies in neurodegenerative disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2008 NOV; 1783 (11): 2195-2206	3	4	65	158
332	25183 Gendron TF, Josephs KA, Petrucelli L Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 97-112	7	7	65	113
333	25246 Yeager MP, Coleman RA In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease JOURNAL OF NEUROSCIENCE METHODS. 2010 APR 30; 188 (1): 151-164	0	0	65	146
334	25975 Kovacs GG, Budka H Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases CLINICAL NEUROPATHOLOGY. 2010 SEP-OCT; 29 (5): 271-288	1	2	65	95
335	10469 Miller CCJ, Ackerley S, Brownlees J, Grierson AJ, Jacobsen NJO, et al. Axonal transport of neurofilaments in normal and disease states CELLULAR AND MOLECULAR LIFE SCIENCES. 2002 FEB; 59 (2): 323-330	21	44	64	117
336	10966 Masliah E, Hansen LA, Rockenstein E, Hashimoto M Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 282-292	2	2	64	107
337	11764 Hashimoto M, Rockenstein E, Crews L, Masliah E Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 21-35	28	88	64	108
338	14816 Yu S, Ueda K, Chan P alpha-Synuclein and dopamine metabolism MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 243-254	21	28	64	89
339	19484 Tofaris GK, Spillantini MG Physiological and pathological properties of alpha-synuclein CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 SEP; 64 (17): 2194-2201	23	30	64	82
340	20137 Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G Truncation of tau protein and its pathological significance in Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 401-409	6	10	64	109
#	Date / Author / Journal	LCS	GCS	LCR	CR
341	22107 Jakob-Roetne R, Jacobsen H Alzheimer's Disease: From Pathology to Therapeutic Approaches ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2009; 48 (17): 3030-3059	2	29	64	310
342	22736 Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, et al. Phosphorylation does not prompt, nor prevent, the formation of alpha- synuclein toxic species in a rat model of Parkinson's disease HUMAN MOLECULAR GENETICS. 2009 MAR 1; 18 (5): 872-887	9	12	64	104
343	24174 Bisaglia M, Tessari I, Mammi S, Bubacco L Interaction Between alpha-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson's Disease NEUROMOLECULAR MEDICINE. 2009 DEC; 11 (4): 239-251	2	2	64	98
344	25922 Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, et al. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis HUMAN MOLECULAR GENETICS. 2010 AUG 15; 19 (16): 3233-3253	0	0	64	184
345	26250 Ruiperez V, Darios F, Davletov B Alpha-synuclein, lipids and Parkinson's disease PROGRESS IN LIPID RESEARCH. 2010 OCT; 49 (4): 420-428	0	0	64	139
346	26297 Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, et al. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1 EMBO JOURNAL. 2010 OCT 20; 29 (20): 3571-3589	0	0	64	133
347	26404 Angot E, Steiner JA, Hansen C, Li JY, Brundin P Are synucleinopathies prion-like disorders? LANCET NEUROLOGY. 2010 NOV; 9 (11): 1128-1138	0	0	64	118
348	9732 Dickson DW alpha-Synuclein and the Lewy body disorders CURRENT OPINION IN NEUROLOGY. 2001 AUG; 14 (4): 423-432	79	95	63	85
349	13121 Burkhard PR, Fournier R, Mermillod B, Krause KH, Bouras C, et al. Cerebrospinal fluid tau and A beta 42 concentrations in healthy subjects: delineation of reference intervals and their limitations CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2004; 42 (4): 396-407	4	5	63	110
350	13315 Lariviere RC, Julien JP Functions of intermediate filaments in neuronal development and disease JOURNAL OF NEUROBIOLOGY. 2004 JAN; 58 (1): 131-148	51	126	63	130
#	Date / Author / Journal	LCS	GCS	LCR	CR
351	13807 Faghihi MA, Mottagui-Tobor S, Wahlestedt C Genetics of neurological disorders EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2004 MAY; 4 (3): 317-332	1	3	63	158
352	15029 Corti O, Hampe C, Darios F, Ibanez P, Ruberg A, et al. Parkinson's disease: from causes to mechanisms COMPTES RENDUS BIOLOGIES. 2005 FEB; 328 (2): 131-142	5	20	63	118
353	15845 Lu BW Understanding and treating neurodegeneration: insights from the flies AGE. 2005 SEP; 27 (3): 225-239	0	0	63	128
354	19252 Tan EK, Skipper LM Pathogenic mutations in Parkinson disease HUMAN MUTATION. 2007 JUL; 28 (7): 641-653	16	70	63	174
355	25626 Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update HUMAN MUTATION. 2010 JUL; 31 (7): 763-780	1	3	63	312
356	26518 Nassif M, Matus S, Castillo K, Hetz C Amyotrophic Lateral Sclerosis Pathogenesis: A Journey Through the Secretory Pathway ANTIOXIDANTS & REDOX SIGNALING. 2010 DEC; 13 (12): 1955-1989	0	0	63	365
357	7456 Jellinger KA What is new in degenerative dementia disorders? WIENER KLINISCHE WOCHENSCHRIFT. 1999 SEP 17; 111 (17): 682-704	3	10	62	252
358	8130 Spillantini MG, Van Swieten JC, Goedert M Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) NEUROGENETICS. 2000 MAR; 2 (4): 193-205	61	68	62	92
359	11768 Moore DJ, Dawson VL, Dawson TM Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 95-108	12	26	62	98
360	11802 Hashimoto M, Rockenstein E, Masliah E Transgenic models of alpha-synuclein pathology - Past, present, and future PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 171-188	33	39	62	83
#	Date / Author / Journal	LCS	GCS	LCR	CR
361	12788 Chung KKK, Dawson VL, Dawson TM New insights into Parkinson's disease JOURNAL OF NEUROLOGY. 2003 OCT; 250: 15-24	16	30	62	106
362	13090 Gamblin TC, Berry RW, Binder LI Modeling Tau polymerization in vitro: A review and synthesis BIOCHEMISTRY. 2003 DEC 30; 42 (51): 15009-15017	47	65	62	95
363	13215 Hampel H, Teipel S, Faltraco F, Brettschneider S, Goernitz A, et al. Advances in the development of biomarkers for Alzheimer's disease - From CSF total tau and amyloid-(beta 1-42) proteins to phosphorylated tau and amyloid-beta-antibodies MOLECULAR NEUROBIOLOGY OF ALZHEIMER DISEASE AND RELATED DISORDERS. 2004; : 134-156	0	0	62	120
364	14969 Kosik KS, Shimura H Phosphorylated tau and the neurodegenerative foldopathies BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 298-310	38	58	62	137
365	21245 Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, et al. Protein folding diseases and neurodegeneration: Lessons learned from yeast BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2008 JUL; 1783 (7): 1381-1395	9	14	62	171
366	22081 McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, et al. Tau Isoform Regulation Is Region- and Cell-Specific in Mouse Brain JOURNAL OF COMPARATIVE NEUROLOGY. 2008 DEC 20; 511 (6): 788-803	5	7	62	87
367	22412 Altar CA, Vawter MP, Ginsberg SD Target Identification for CNS Diseases by Transcriptional Profiling NEUROPSYCHOPHARMACOLOGY. 2009 JAN; 34 (1): 18-54	4	23	62	397
368	25144 Waxman EA, Giasson BI A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation JOURNAL OF NEUROCHEMISTRY. 2010 APR; 113 (2): 374-388	4	5	62	72
369	25226 Cushman M, Johnson BS, King OD, Gitler AD, Shorter J Prion-like disorders: blurring the divide between transmissibility and infectivity JOURNAL OF CELL SCIENCE. 2010 APR 15; 123 (8): 1191-1201	3	5	62	179
370	2909 DOERING LC PROBING MODIFICATIONS OF THE NEURONAL CYTOSKELETON MOLECULAR NEUROBIOLOGY. 1993 FAL-WIN; 7 (3-4): 265-291	6	10	61	255
#	Date / Author / Journal	LCS	GCS	LCR	CR
371	8170 Gutierrez C, Cola MG, Seltzer B, Cusick C Neurochemical and connectional organization of the dorsal pulvinar complex in monkeys JOURNAL OF COMPARATIVE NEUROLOGY. 2000 MAR 27; 419 (1): 61-86	10	35	61	131
372	10935 Giasson BI, Ischiropoulos H, Lee VMY, Trojanowski JQ The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases FREE RADICAL BIOLOGY AND MEDICINE. 2002 JUN 15; 32 (12): 1264-1275	125	125	61	194
373	12598 Hampel H, Goernitz A, Buerger K Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and A beta(1-42) proteins to phosphorylated tau protein BRAIN RESEARCH BULLETIN. 2003 AUG 15; 61 (3): 243-253	15	30	61	98
374	14485 Everett CM, Wood NW Trinucleotide repeats and neurodegenerative disease BRAIN. 2004 NOV; 127: 2385-2405	12	78	61	287
375	15212 Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, et al. Metal-catalyzed oxidation of alpha-synuclein - Helping to define the relationship between oligomers, protofibrils, and filaments JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 11; 280 (10): 9678-9690	28	40	61	103
376	17211 Gaggelli E, Kozlowski H, Valensin D, Valensin G Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis) CHEMICAL REVIEWS. 2006 JUN; 106 (6): 1995-2044	17	182	61	430
377	17455 Melrose HL, Lincoln SJ, Tyndall GM, Farrer MJ Parkinson's disease: a rethink of rodent models EXPERIMENTAL BRAIN RESEARCH. 2006 AUG; 173 (2): 196-204	15	31	61	99
378	17818 Pittman AM, Fung HC, de Silva R Untangling the tau gene association with neurodegenerative disorders HUMAN MOLECULAR GENETICS. 2006 OCT 15; 15: R188-R195	21	24	61	86
379	18186 Ramsey CP, Giasson BI Role of mitochondrial dysfunction in Parkinson's disease - Implications for treatment DRUGS & AGING. 2007; 24 (2): 95-105	4	7	61	134
380	19377 Brown DR Interactions between metals and alpha-synuclein - function or artefact? FEBS JOURNAL. 2007 AUG; 274 (15): 3766-3774	6	12	61	77
#	Date / Author / Journal	LCS	GCS	LCR	CR
381	20299 Szargel R, Rott R, Engelender S Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation CELLULAR AND MOLECULAR LIFE SCIENCES. 2008 JAN; 65 (1): 80-88	5	7	61	80
382	21295 Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases MOLECULAR MEDICINE. 2008 JUL-AUG; 14 (7-8): 451-464	11	39	61	153
383	21478 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, et al. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 219-230	6	18	61	178
384	21972 Cole NB Metal Catalyzed Oxidation of Alpha-Synuclein - A Role for Oligomerization in Pathology? CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 599-606	1	1	61	121
385	23780 Lindner AB, Demarez A Protein aggregation as a paradigm of aging BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2009 OCT; 1790 (10): 980-996	0	6	61	345
386	25259 Feany MB New Approaches to the Pathology and Genetics of Neurodegeneration AMERICAN JOURNAL OF PATHOLOGY. 2010 MAY; 176 (5): 2058-2066	1	2	61	100
387	3300 MOLENAAR WM, Trojanowski JQ PRIMITIVE NEUROECTODERMAL TUMORS OF THE CENTRAL-NERVOUS-SYSTEM IN CHILDHOOD - TUMOR BIOLOGICAL ASPECTS CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. 1994 AUG; 17 (1): 1-25	21	21	60	260
388	4402 Burack MA, Halpain S Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons NEUROSCIENCE. 1996 MAY; 72 (1): 167-184	24	26	60	104
389	11409 Robertson J, Kriz J, Nguyen MD, Julien JP Pathways to motor neuron degeneration in transgenic mouse models BIOCHIMIE. 2002 NOV; 84 (11): 1151-1160	9	24	60	112
390	11811 Lalonde R, Strazielle C Neurobehavioral characteristics of mice with modified intermediate filament genes REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 369-385	2	8	60	143
#	Date / Author / Journal	LCS	GCS	LCR	CR
391	12843 Ciechanover A, Brundin P The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg NEURON. 2003 OCT 9; 40 (2): 427-446	101	319	60	164
392	13534 Giasson BI, Lee VMY, Trojanowski JQ Animal models of neurodegenerative dementing disorders other than Alzheimer's disease CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 427-436	3	3	60	89
393	17037 Reynolds MR, Lukas TJ, Berry RW, Binder LI Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms BIOCHEMISTRY. 2006 APR 4; 45 (13): 4314-4326	12	16	60	119
394	17469 Gotz J, Ittner LM, Kins S Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 993-1006	23	37	60	148
395	19209 Pickering-Brown SM Progranulin and frontotemporal lobar degeneration ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 39-47	15	16	60	103
396	19497 Paquet-Durand F, Bicker G Human model neurons in studies of brain cell damage and neural repair CURRENT MOLECULAR MEDICINE. 2007 SEP; 7 (6): 541-554	3	6	60	152
397	20709 Kawahara K, Hashimoto M, Bar-On P, Ho GJ, Crews L, et al. alpha-Synuclein aggregates interfere with parkin solubility and distribution - Role in the pathogenesis of Parkinson disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 MAR 14; 283 (11): 6979-6987	9	14	60	80
398	21459 Armstrong RA, Lantos PL, Cairns NJ What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? NEUROPATHOLOGY. 2008 AUG; 28 (4): 351-365	6	11	60	151
399	23251 Shepherd C, McCann H, Halliday GM Variations in the neuropathology of familial Alzheimer's disease ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 37-52	4	7	60	231
400	23486 Wright JA, Wang XY, Brown DR Unique copper-induced oligomers mediate alpha-synuclein toxicity FASEB JOURNAL. 2009 AUG; 23 (8): 2384-2393	11	13	60	84

Date / Author / Journal

LCS

GCS

LCR

301

21446 Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, et al.

The ART of loss: A beta imaging in the evaluation of Alzheimer's disease and other dementias

MOLECULAR NEUROBIOLOGY. 2008 AUG; 38 (1): 1-15

186

302

22446 Kell DB

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

BMC MEDICAL GENOMICS. 2009 JAN 8; 2: Art. No. 2

2468

303

24154 Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, et al.

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

LANCET NEUROLOGY. 2009 DEC; 8 (12): 1150-1157

304

25664 van Blitterswijk M, Landers JE

RNA processing pathways in amyotrophic lateral sclerosis

NEUROGENETICS. 2010 JUL; 11 (3): 275-290

244

305

26533 Xilouri M, Stefanis L

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 701-719

290

306

26922 Piguet O, Hornberger M, Mioshi E, Hodges JR

Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management

LANCET NEUROLOGY. 2011 FEB; 10 (2): 162-172

130

307

7809 Goedert M, Spillantini MG

Tauopathies and alpha-synucleinopathies

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 65-86

308

7811 Buee L, Mailliot C, Bussiere T, Sergeant N, Buee-Scherrer V, et al.

Neurodegenerative disorders with tauopathies: Mad tau diseases?

FATAL ATTRACTIONS: PROTEIN AGGREGATES IN NEURODEGENERATIVE DISORDERS. 2000; : 105-125

105

309

9061 Goedert M, Spillantini MG

Tau gene mutations and neurodegeneration

NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE. 2001; (67): 59-71

310

9195 Reed LA, Wszolek ZK, Hutton M

Phenotypic correlations in FTDP-17

NEUROBIOLOGY OF AGING. 2001 JAN-FEB; 22 (1): 89-107

113

127

107

Date / Author / Journal

311

alpha-synuclein and Parkinson's disease

PARKINSON'S DISEASE. 2003; 91: 165-174

312

12678 Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K

The role of alpha-synuclein in Parkinson's disease: Insights from animal models

NATURE REVIEWS NEUROSCIENCE. 2003 SEP; 4 (9): 727-738

103

313

12702 Dauer W, Przedborski S

Parkinson's disease: Mechanisms and models

NEURON. 2003 SEP 11; 39 (6): 889-909

243

861

235

314

17937 Abeliovich A, Beal MF

Parkinsonism genes: culprits and clues

JOURNAL OF NEUROCHEMISTRY. 2006 NOV; 99 (4): 1062-1072

118

315

20036 Strong MJ

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS. 2008; 9 (6): 323-338

213

316

20982 Turner BJ, Talbot K

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1- mediated familial ALS

PROGRESS IN NEUROBIOLOGY. 2008 MAY; 85 (1): 94-134

438

317

22491 Jellinger KA

Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?

ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 101-110

160

318

23147 Yin J, Chen RZ, Liu CL

Nucleic acid induced protein aggregation and its role in biology and pathology

FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5084-5106

189

319

23282 Yacoubian TA, Standaert DG

Targets for neuroprotection in Parkinson's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 676-687

244

320

23454 Lu BW

Recent advances in using Drosophila to model neurodegenerative diseases

APOPTOSIS. 2009 AUG; 14 (8): 1008-1020

142

Date / Author / Journal

321

Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20: S335-S356

204

322

24574 Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, et al.

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

EXPERIMENTAL GERONTOLOGY. 2010 JAN; 45 (1): 30-40

111

323

25278 Shi M, Huber BR, Zhang J

Biomarkers for Cognitive Impairment in Parkinson Disease

BRAIN PATHOLOGY. 2010 MAY; 20 (3): 660-671

149

324

26847 Greggio E, Bisaglia M, Civiero L, Bubacco L

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?

MOLECULAR NEURODEGENERATION. 2011 JAN 18; 6: Art. No. 6

124

325

9018 Cassimeris L, Spittle C

Regulation of microtubule-associated proteins

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 210. 2001; 210: 163-226

483

326

10909 Takashima A

Neurofibrillary tangles and neurodegenerative disease

SEIKAGAKU. 2002 JUN; 74 (6): 461-470

327

11781 Botas J

Neurodegenerative diseases: Insights from Drosophila and mouse models

NEUROSCIENCES IN THE POSTGENOMIC ERA. 2003; : 85-103

106

328

18326 Martin LJ

Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration

REVIEWS IN THE NEUROSCIENCES. 2007; 18 (2): 115-136

163

329

18364 Kumar-Singh S, Van Broeckhoven C

Frontotemporal lobar degeneration: Current concepts in the light of recent advances

BRAIN PATHOLOGY. 2007 JAN; 17 (1): 104-113

117

330

19410 Haugarvoll K, Wszolek ZK, Hutton M

The genetics of frontotemporal dementia

NEUROLOGIC CLINICS. 2007 AUG; 25 (3): 697-+

Date / Author / Journal

331

Nuclear bodies in neurodegenerative disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2008 NOV; 1783 (11): 2195-2206

158

332

25183 Gendron TF, Josephs KA, Petrucelli L

Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 APR; 36 (2): 97-112

113

333

25246 Yeager MP, Coleman RA

In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease

JOURNAL OF NEUROSCIENCE METHODS. 2010 APR 30; 188 (1): 151-164

146

334

25975 Kovacs GG, Budka H

Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases

CLINICAL NEUROPATHOLOGY. 2010 SEP-OCT; 29 (5): 271-288

335

10469 Miller CCJ, Ackerley S, Brownlees J, Grierson AJ, Jacobsen NJO, et al.

Axonal transport of neurofilaments in normal and disease states

CELLULAR AND MOLECULAR LIFE SCIENCES. 2002 FEB; 59 (2): 323-330

117

336

10966 Masliah E, Hansen LA, Rockenstein E, Hashimoto M

Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases

DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 282-292

107

337

11764 Hashimoto M, Rockenstein E, Crews L, Masliah E

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 21-35

108

338

14816 Yu S, Ueda K, Chan P

alpha-Synuclein and dopamine metabolism

MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 243-254

339

19484 Tofaris GK, Spillantini MG

Physiological and pathological properties of alpha-synuclein

CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 SEP; 64 (17): 2194-2201

340

20137 Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G

Truncation of tau protein and its pathological significance in Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 401-409

109

Date / Author / Journal

LCS

GCS

LCR

341

22107 Jakob-Roetne R, Jacobsen H

Alzheimer's Disease: From Pathology to Therapeutic Approaches

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2009; 48 (17): 3030-3059

310

342

22736 Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, et al.

Phosphorylation does not prompt, nor prevent, the formation of alpha- synuclein toxic species in a rat model of Parkinson's disease

HUMAN MOLECULAR GENETICS. 2009 MAR 1; 18 (5): 872-887

104

343

24174 Bisaglia M, Tessari I, Mammi S, Bubacco L

Interaction Between alpha-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson's Disease

NEUROMOLECULAR MEDICINE. 2009 DEC; 11 (4): 239-251

344

25922 Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, et al.

Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis

HUMAN MOLECULAR GENETICS. 2010 AUG 15; 19 (16): 3233-3253

184

345

26250 Ruiperez V, Darios F, Davletov B

Alpha-synuclein, lipids and Parkinson's disease

PROGRESS IN LIPID RESEARCH. 2010 OCT; 49 (4): 420-428

139

346

26297 Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, et al.

Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1

EMBO JOURNAL. 2010 OCT 20; 29 (20): 3571-3589

133

347

26404 Angot E, Steiner JA, Hansen C, Li JY, Brundin P

Are synucleinopathies prion-like disorders?

LANCET NEUROLOGY. 2010 NOV; 9 (11): 1128-1138

118

348

9732 Dickson DW

alpha-Synuclein and the Lewy body disorders

CURRENT OPINION IN NEUROLOGY. 2001 AUG; 14 (4): 423-432

349

13121 Burkhard PR, Fournier R, Mermillod B, Krause KH, Bouras C, et al.

Cerebrospinal fluid tau and A beta 42 concentrations in healthy subjects: delineation of reference intervals and their limitations

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2004; 42 (4): 396-407

110

350

13315 Lariviere RC, Julien JP

Functions of intermediate filaments in neuronal development and disease

JOURNAL OF NEUROBIOLOGY. 2004 JAN; 58 (1): 131-148

126

130

Date / Author / Journal

LCS

GCS

LCR

351

13807 Faghihi MA, Mottagui-Tobor S, Wahlestedt C

Genetics of neurological disorders

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2004 MAY; 4 (3): 317-332

158

352

15029 Corti O, Hampe C, Darios F, Ibanez P, Ruberg A, et al.

Parkinson's disease: from causes to mechanisms

COMPTES RENDUS BIOLOGIES. 2005 FEB; 328 (2): 131-142

118

353

15845 Lu BW

Understanding and treating neurodegeneration: insights from the flies

AGE. 2005 SEP; 27 (3): 225-239

128

354

19252 Tan EK, Skipper LM

Pathogenic mutations in Parkinson disease

HUMAN MUTATION. 2007 JUL; 28 (7): 641-653

174

355

25626 Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C

Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update

HUMAN MUTATION. 2010 JUL; 31 (7): 763-780

312

356

26518 Nassif M, Matus S, Castillo K, Hetz C

Amyotrophic Lateral Sclerosis Pathogenesis: A Journey Through the Secretory Pathway

ANTIOXIDANTS & REDOX SIGNALING. 2010 DEC; 13 (12): 1955-1989

365

357

7456 Jellinger KA

What is new in degenerative dementia disorders?

WIENER KLINISCHE WOCHENSCHRIFT. 1999 SEP 17; 111 (17): 682-704

252

358

8130 Spillantini MG, Van Swieten JC, Goedert M

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

NEUROGENETICS. 2000 MAR; 2 (4): 193-205

359

11768 Moore DJ, Dawson VL, Dawson TM

Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses

NEUROMOLECULAR MEDICINE. 2003; 4 (1-2): 95-108

360

11802 Hashimoto M, Rockenstein E, Masliah E

Transgenic models of alpha-synuclein pathology - Past, present, and future

PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON. 2003; 991: 171-188

Date / Author / Journal

LCS

GCS

LCR

361

12788 Chung KKK, Dawson VL, Dawson TM

New insights into Parkinson's disease

JOURNAL OF NEUROLOGY. 2003 OCT; 250: 15-24

106

362

13090 Gamblin TC, Berry RW, Binder LI

Modeling Tau polymerization in vitro: A review and synthesis

BIOCHEMISTRY. 2003 DEC 30; 42 (51): 15009-15017

363

13215 Hampel H, Teipel S, Faltraco F, Brettschneider S, Goernitz A, et al.

Advances in the development of biomarkers for Alzheimer's disease - From CSF total tau and amyloid-(beta 1-42) proteins to phosphorylated tau and amyloid-beta-antibodies

MOLECULAR NEUROBIOLOGY OF ALZHEIMER DISEASE AND RELATED DISORDERS. 2004; : 134-156

120

364

14969 Kosik KS, Shimura H

Phosphorylated tau and the neurodegenerative foldopathies

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 298-310

137

365

21245 Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, et al.

Protein folding diseases and neurodegeneration: Lessons learned from yeast

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2008 JUL; 1783 (7): 1381-1395

171

366

22081 McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, et al.

Tau Isoform Regulation Is Region- and Cell-Specific in Mouse Brain

JOURNAL OF COMPARATIVE NEUROLOGY. 2008 DEC 20; 511 (6): 788-803

367

22412 Altar CA, Vawter MP, Ginsberg SD

Target Identification for CNS Diseases by Transcriptional Profiling

NEUROPSYCHOPHARMACOLOGY. 2009 JAN; 34 (1): 18-54

397

368

25144 Waxman EA, Giasson BI

A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation

JOURNAL OF NEUROCHEMISTRY. 2010 APR; 113 (2): 374-388

369

25226 Cushman M, Johnson BS, King OD, Gitler AD, Shorter J

Prion-like disorders: blurring the divide between transmissibility and infectivity

JOURNAL OF CELL SCIENCE. 2010 APR 15; 123 (8): 1191-1201

179

370

2909 DOERING LC

PROBING MODIFICATIONS OF THE NEURONAL CYTOSKELETON

MOLECULAR NEUROBIOLOGY. 1993 FAL-WIN; 7 (3-4): 265-291

255

Date / Author / Journal

LCS

GCS

LCR

371

8170 Gutierrez C, Cola MG, Seltzer B, Cusick C

Neurochemical and connectional organization of the dorsal pulvinar complex in monkeys

JOURNAL OF COMPARATIVE NEUROLOGY. 2000 MAR 27; 419 (1): 61-86

131

372

10935 Giasson BI, Ischiropoulos H, Lee VMY, Trojanowski JQ

The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases

FREE RADICAL BIOLOGY AND MEDICINE. 2002 JUN 15; 32 (12): 1264-1275

125

194

373

12598 Hampel H, Goernitz A, Buerger K

Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and A beta(1-42) proteins to phosphorylated tau protein

BRAIN RESEARCH BULLETIN. 2003 AUG 15; 61 (3): 243-253

374

14485 Everett CM, Wood NW

Trinucleotide repeats and neurodegenerative disease

BRAIN. 2004 NOV; 127: 2385-2405

287

375

15212 Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, et al.

Metal-catalyzed oxidation of alpha-synuclein - Helping to define the relationship between oligomers, protofibrils, and filaments

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 MAR 11; 280 (10): 9678-9690

103

376

17211 Gaggelli E, Kozlowski H, Valensin D, Valensin G

Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis)

CHEMICAL REVIEWS. 2006 JUN; 106 (6): 1995-2044

182

430

377

17455 Melrose HL, Lincoln SJ, Tyndall GM, Farrer MJ

Parkinson's disease: a rethink of rodent models

EXPERIMENTAL BRAIN RESEARCH. 2006 AUG; 173 (2): 196-204

378

17818 Pittman AM, Fung HC, de Silva R

Untangling the tau gene association with neurodegenerative disorders

HUMAN MOLECULAR GENETICS. 2006 OCT 15; 15: R188-R195

379

18186 Ramsey CP, Giasson BI

Role of mitochondrial dysfunction in Parkinson's disease - Implications for treatment

DRUGS & AGING. 2007; 24 (2): 95-105

134

380

19377 Brown DR

Interactions between metals and alpha-synuclein - function or artefact?

FEBS JOURNAL. 2007 AUG; 274 (15): 3766-3774

Date / Author / Journal

LCS

GCS

LCR

381

20299 Szargel R, Rott R, Engelender S

Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation

CELLULAR AND MOLECULAR LIFE SCIENCES. 2008 JAN; 65 (1): 80-88

382

21295 Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM

Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases

MOLECULAR MEDICINE. 2008 JUL-AUG; 14 (7-8): 451-464

153

383

21478 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, et al.

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 219-230

178

384

21972 Cole NB

Metal Catalyzed Oxidation of Alpha-Synuclein - A Role for Oligomerization in Pathology?

CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 599-606

121

385

23780 Lindner AB, Demarez A

Protein aggregation as a paradigm of aging

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 2009 OCT; 1790 (10): 980-996

345

386

25259 Feany MB

New Approaches to the Pathology and Genetics of Neurodegeneration

AMERICAN JOURNAL OF PATHOLOGY. 2010 MAY; 176 (5): 2058-2066

100

387

3300 MOLENAAR WM, Trojanowski JQ

PRIMITIVE NEUROECTODERMAL TUMORS OF THE CENTRAL-NERVOUS-SYSTEM IN CHILDHOOD - TUMOR BIOLOGICAL ASPECTS

CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. 1994 AUG; 17 (1): 1-25

260

388

4402 Burack MA, Halpain S

Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons

NEUROSCIENCE. 1996 MAY; 72 (1): 167-184

104

389

11409 Robertson J, Kriz J, Nguyen MD, Julien JP

Pathways to motor neuron degeneration in transgenic mouse models

BIOCHIMIE. 2002 NOV; 84 (11): 1151-1160

112

390

11811 Lalonde R, Strazielle C

Neurobehavioral characteristics of mice with modified intermediate filament genes

REVIEWS IN THE NEUROSCIENCES. 2003; 14 (4): 369-385

143

Date / Author / Journal

LCS

GCS

LCR

391

12843 Ciechanover A, Brundin P

The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg

NEURON. 2003 OCT 9; 40 (2): 427-446

101

319

164

392

13534 Giasson BI, Lee VMY, Trojanowski JQ

Animal models of neurodegenerative dementing disorders other than Alzheimer's disease

CLINICAL NEUROSCIENCE RESEARCH. 2004 MAR-APR; 3 (6): 427-436

393

17037 Reynolds MR, Lukas TJ, Berry RW, Binder LI

Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms

BIOCHEMISTRY. 2006 APR 4; 45 (13): 4314-4326

119

394

17469 Gotz J, Ittner LM, Kins S

Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?

JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (4): 993-1006

148

395

19209 Pickering-Brown SM

Progranulin and frontotemporal lobar degeneration

ACTA NEUROPATHOLOGICA. 2007 JUL; 114 (1): 39-47

103

396

19497 Paquet-Durand F, Bicker G

Human model neurons in studies of brain cell damage and neural repair

CURRENT MOLECULAR MEDICINE. 2007 SEP; 7 (6): 541-554

152

397

20709 Kawahara K, Hashimoto M, Bar-On P, Ho GJ, Crews L, et al.

alpha-Synuclein aggregates interfere with parkin solubility and distribution - Role in the pathogenesis of Parkinson disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 MAR 14; 283 (11): 6979-6987

398

21459 Armstrong RA, Lantos PL, Cairns NJ

What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?

NEUROPATHOLOGY. 2008 AUG; 28 (4): 351-365

151

399

23251 Shepherd C, McCann H, Halliday GM

Variations in the neuropathology of familial Alzheimer's disease

ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 37-52

231

400

23486 Wright JA, Wang XY, Brown DR

Unique copper-induced oligomers mediate alpha-synuclein toxicity

FASEB JOURNAL. 2009 AUG; 23 (8): 2384-2393

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records